1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 245 F.Supp.2d
  5. 245 F.Supp.2d 280 (2003)
 

IN RE LUPRON MARKETING AND SALES PRACTICES LITIGATION

Nos. MDL 1430, 01-CV-10861-RGS.

245 F.Supp.2d 280 (2003)

In re: LUPRON® MARKETING AND SALES PRACTICES LITIGATION

United States District Court, D. Massachusetts.

Order Denying Reconsideration February 19, 2003.

Attorney(s) appearing for the Case

Thomas G. Shapiro, Shapiro, Haber & Urmy, LLP, Boston, MA, Jeffrey Kodroff, Spector & Roseman, Philadelphia, PA, Thomas M. Sobol, Lieff, Cabraser, Heimann & Bernstein, LLP, Boston, MA, for Plaintiff.

Deborah S. Birnbach, Joseph F. Savage, Testa, Hurwitz & Thibeault, LLP, Boston, MA, Daniel A. Curto, McDermott, Will & Emery, Martin F. Murphy, Rheba Rutkowski, Fiona S. Trevelyan, Bingham McCutchen LLP, Boston, MA, for Defendants.

MEMORANDUM AND ORDER ON DEFENDANT TAKEDA'S MOTION TO DISMISS FOR WANT OF PERSONAL JURISDICTION

STEARNS, District Judge.

A consortium of patients and health care plans maintains that defendants Abbott Laboratories ("Abbott"), Takeda Chemical Industries, Ltd. ("Takeda") and TAP Pharmaceutical Products, Inc. ("TAP") (an Illinois corporation owned by Abbott and Takeda) conspired to artificially inflate the price for the cancer drug Lupron®.

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases